Daniel Joseph OConnell - Nov 30, 2021 Form 4 Insider Report for Acumen Pharmaceuticals, Inc. (ABOS)

Role
President and CEO, Director
Signature
/s/ Katie Lapidus, Attorney-in-Fact
Stock symbol
ABOS
Transactions as of
Nov 30, 2021
Transactions value $
$4,997
Form type
4
Date filed
12/2/2021, 03:41 PM
Previous filing
Jul 8, 2021
Next filing
Jan 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABOS Common Stock Options Exercise $5K +1.12K +71.35% $4.47 2.69K Nov 30, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABOS Stock Option (Right to Buy) Options Exercise $0 -1.12K -100% $0.00* 0 Nov 30, 2021 Common Stock 1.12K $4.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Immediately exercisable.